Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Warfarin found to increase adverse outcomes among transplant patients IPF

Key clinical point: Patients with interstitial lung disease who need anticoagulation therapy may have poorer long-term outcomes on warfarin than with oral anticoagulants.

Major finding: Compared with oral therapy, warfarin doubled the risk of lung transplant or death.

Study details: The retrospective cohort study comprised 1,918 patients.

Disclosures: Dr. King had no disclosures.

Citation:

REPORTING FROM ATS 2019